Group B:anlotinib combined with iodine-125 seed implantation

2 trials

Sponsors

The First People's Hospital of Yueyang

Conditions

Non-Small Cell Lung Cancercervical cancer

Phase 2

Phase II Clinical Study for Anlotinib Combined with Radioactive 125I Seed Implantation in Three-line Treatment of Recurrent or Metastatic Advanced Cervical Cancer

Active, not recruitingChiCTR1900020906

The First People's Hospital of Yueyangcervical cancer

Start: 2019-06-01Updated: 2019-01-28

Phase II Clinical Study for Anlotinib Combined with Radioactive 125I Seed Implantation in Three-line Treatment of Recurrent or Metastatic Advanced Non-Small Cell Lung Cancer

Active, not recruitingChiCTR1900020911

The First People's Hospital of YueyangNon-Small Cell Lung Cancer

Start: 2019-06-01Updated: 2019-01-28